Sanjay Kaul, MBBS

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Boehringer-Ingelhiem(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT), AstraZeneca(SIGNIFICANT), Amarin(SIGNIFICANT), GSK(SIGNIFICANT) OWNERSHIP/PARTNERSHIP/PRINCIPAL: JNJ(SIGNIFICANT)

View Full Disclosure